Company: VRCA
Filing Date: 2025-05-13
Form Type: S-8
Source: 0001193125-25-118881
Chunk: 2

Company: Verrica Pharmaceuticals Inc.
Filing Date: 2025-05-13
Form: S-8
Chunk 2
---
 |

| (2) | Previously filed as Exhibit 3.4 to the Registrant’s Registration Statement on Form S-1 (File No. 333-225104), filed with the Commission on May 22, 2018, and incorporated by reference herein. |

| (3) | Previously filed as Exhibit 10.4 to Amendment No. 1 to the Registrant’s Registration Statement on                
 Form S-1 (File No. 333-225104), filed with the Commission on June 5, 2018, and incorporated by reference herein. |

| (4) | Previously filed as Exhibit 10.5 to Amendment No. 1 to the Registrant’s Registration Statement on                
 Form S-1 (File No. 333-225104), filed with the Commission on June 5, 2018, and incorporated by reference herein. |

3

| ITEM 9. | UNDERTAKINGS |

| 1. | The undersigned registrant hereby undertakes: |

(a)To file, during any period in which offers or sales are being made, a post-effective amendment to this registration statement: (i)To include any prospectus required by Section 10(a)(3) of the Securities Act; (ii)To reflect in the prospectus any facts or events arising after the effective date of the registration statement (or the most recent post-effective amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set forth in the registration statement. Notwithstanding the foregoing, any increase or decrease in volume of securities offered (if the total dollar value of securities offered would not exceed that which was registered) and any deviation from the low or high end of the estimated maximum offering range may be reflected in the form of prospectus filed with the Commission pursuant to Rule 424(b) if, in the aggregate, the changes in volume and price represent no more than a 20% change in the maximum aggregate offering price set forth in the “Calculation of Registration Fee” table in the effective registration statement. (iii)To include any material information with respect to the plan of distribution not previously disclosed in the registration statement or any material change to such information in the registration statement; Provided, however, that paragraphs (a)(i) and (a)(ii) do not apply if the information required to be included in a post-effective amendment by those paragraphs is contained in reports filed with or furnished to the Commission by the registrant pursuant to section 13